Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study

Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study

Abstract Background Vernakalant is authorized in several countries, except in the U.S., where the FDA denied its commercialization due to safety concerns, generating debate about its use. Objective To compare the effectiveness and safety of intravenous (iv) vernakalant and iv flecainide in the conve...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Dominijanni, Antonio F. Caballero-Bermejo, Ana Sainz-Herrero, Álvaro Pineda-Torcuato, Rosa Capilla-Pueyo, Belén Ruiz-Antorán
Format: Article
Language:English
Published: BMC 2025-08-01
Series:International Journal of Emergency Medicine
Subjects:
Atrial fibrillation
Vernakalant hydrochloride
Flecainide
Arrhythmias
Cardiac
Emergency treatment
Online Access:https://doi.org/10.1186/s12245-025-00951-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items